Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/99091

In Collections

This item can be found in the following collections:

Casali, P.G.; Reichardt, P.; Kang, Y.; Blay, J.; Rutkowski, P.; Gelderblom, H.; ... ; Demetri, G.D. (2012)

CLINICAL BENEFIT WITH REGORAFENIB ACROSS SUBGROUPS AND POST-PROGRESSION IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) AFTER PROGRESSION ON IMATINIB (IM) AND SUNITINIB (SU): PHASE 3 GRID TRIAL UPDATE

Article / Letter to editor
All authors
Casali, P.G.; Reichardt, P.; Kang, Y.; Blay, J.; Rutkowski, P.; Gelderblom, H.; Hohenberger, P.; Leahy, M.; Mehren, M. von; Joensuu, H.; Badalamenti, G.; Blackstein, M.; Cesne, A. le; Schoffski, P.; Maki, R.; Xu, J.; Nishida, T.; Kuss, I.; Laurent, D.; Demetri, G.D.
Date
2012-09-30
Journal
Annals of Oncology
Volume
23
Pages
478 - 479